JP2009539961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009539961A5 JP2009539961A5 JP2009514901A JP2009514901A JP2009539961A5 JP 2009539961 A5 JP2009539961 A5 JP 2009539961A5 JP 2009514901 A JP2009514901 A JP 2009514901A JP 2009514901 A JP2009514901 A JP 2009514901A JP 2009539961 A5 JP2009539961 A5 JP 2009539961A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- cannabigerol
- pharmaceutically acceptable
- acceptable salt
- cannabigerovaline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 claims 9
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 7
- 229930003827 cannabinoid Natural products 0.000 claims 6
- 239000003557 cannabinoid Substances 0.000 claims 6
- 241000218236 Cannabis Species 0.000 claims 4
- 208000019022 Mood disease Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000000284 extract Substances 0.000 claims 3
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- YJYIDZLGVYOPGU-UHFFFAOYSA-N cannabigeroldivarin Natural products CCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 YJYIDZLGVYOPGU-UHFFFAOYSA-N 0.000 claims 2
- 229940065144 cannabinoids Drugs 0.000 claims 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 2
- YJYIDZLGVYOPGU-XNTDXEJSSA-N 2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol Chemical compound CCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 YJYIDZLGVYOPGU-XNTDXEJSSA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 238000007915 intraurethral administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81381406P | 2006-06-15 | 2006-06-15 | |
| US60/813,814 | 2006-06-15 | ||
| PCT/GB2007/002216 WO2007144628A1 (en) | 2006-06-15 | 2007-06-14 | Use of pharmaceutical compositions comprising cannabigerol for the treatment of depression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009539961A JP2009539961A (ja) | 2009-11-19 |
| JP2009539961A5 true JP2009539961A5 (enExample) | 2010-07-29 |
| JP5286255B2 JP5286255B2 (ja) | 2013-09-11 |
Family
ID=38353631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009514901A Active JP5286255B2 (ja) | 2006-06-15 | 2007-06-14 | カンナビゲロールを含有する医薬組成物のうつ病の治療のための使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8481085B2 (enExample) |
| EP (1) | EP2037901B1 (enExample) |
| JP (1) | JP5286255B2 (enExample) |
| CA (1) | CA2655094C (enExample) |
| WO (1) | WO2007144628A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1644349B1 (en) * | 2003-06-24 | 2014-04-09 | GW Pharma Limited | Pharmaceutical compositions comprising cabbinochreme type compounds |
| GB2450493A (en) * | 2007-06-25 | 2008-12-31 | Gw Pharma Ltd | Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors |
| GB2456183A (en) * | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
| US20100293021A1 (en) * | 2009-01-23 | 2010-11-18 | Intranet Productivity Solutions, Ltd. | Method and system for task tracking and allocation |
| US8445034B1 (en) | 2010-11-02 | 2013-05-21 | Albert L Coles, Jr. | Systems and methods for producing organic cannabis tincture |
| US10774288B2 (en) | 2013-09-18 | 2020-09-15 | The Werc Shop, LLC | Terpene-based compositions, processes, methodologies for creation and products thereby |
| US10045540B2 (en) | 2014-04-01 | 2018-08-14 | Fayetteville State University | Pest control composition |
| CA3111682A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
| US20160298151A1 (en) | 2015-04-09 | 2016-10-13 | Sher Ali Butt | Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products |
| US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
| JP2019524655A (ja) | 2016-06-29 | 2019-09-05 | キャンサイエンス イノベーションズ インコーポレーテッドＣａｎｎｓｃｉｅｎｃｅ Ｉｎｎｏｖａｔｉｏｎｓ Ｉｎｃ． | 脱炭酸大麻樹脂、その使用、及びそれを製造する方法 |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US10857107B2 (en) | 2017-02-01 | 2020-12-08 | Gbs Global Biopharma, Inc. | Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders |
| US10272360B2 (en) | 2017-08-05 | 2019-04-30 | Priya Naturals, Inc. | Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto |
| EP3720426A4 (en) * | 2017-12-08 | 2021-12-01 | Biotech Institute, LLC | HIGH CANNABIGEROL CONTENT CANNABIS PLANTS, METHOD OF MANUFACTURING AND METHOD OF USING THEREOF |
| US11202771B2 (en) | 2018-01-31 | 2021-12-21 | Treehouse Biotech, Inc. | Hemp powder |
| WO2019199861A2 (en) | 2018-04-09 | 2019-10-17 | Ellevet Sciences | Hemp extract for treatment of pain in animals |
| EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | CANNABIGEROL SYNTHESIS |
| CA3117714A1 (en) * | 2018-10-31 | 2020-05-07 | Baymedica, Inc. | Cannabinoid analogs and methods for their preparation |
| KR20210153052A (ko) | 2019-03-07 | 2021-12-16 | 일레라 테라퓨틱스 엘엘씨 | 자폐증 스펙트럼 장애와 관련된 클러스터 증상을 치료하기 위한 제제 |
| CN114650809A (zh) | 2019-10-03 | 2022-06-21 | 斯塔顿治疗公司 | 屈大麻酚的透皮递送 |
| US12409131B2 (en) | 2019-10-03 | 2025-09-09 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| CN114555548A (zh) * | 2019-10-08 | 2022-05-27 | 贝索制药有限责任公司 | 用于生产大麻素和大麻素酸的方法 |
| US12016829B2 (en) | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| JP7670700B2 (ja) | 2019-10-11 | 2025-04-30 | パイク セラピューティクス インコーポレイテッド | 発作性障害の治療用のカンナビジオール（ｃｂｄ）を含む経皮医薬組成物 |
| US12268699B2 (en) | 2019-10-14 | 2025-04-08 | Pike Therapeutics Inc. | Transdermal delivery of tetrahydrocannabinol |
| WO2021074790A1 (en) | 2019-10-14 | 2021-04-22 | Pike Therapeutics, Inc., 1219014 B.C. Ltd. | Transdermal delivery of cannabidiol |
| US12121617B2 (en) | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| JP2023503601A (ja) * | 2019-11-26 | 2023-01-31 | キャノピー グロウス コーポレイション | カンナビゲロール誘導体、およびカンナビノイド受容体モジュレーターとしてのその使用 |
| JP2023503330A (ja) * | 2019-11-26 | 2023-01-27 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US20230059582A1 (en) * | 2019-12-09 | 2023-02-23 | Canopy Growth Corporation | Cannabinoid derivatives |
| US11767306B2 (en) | 2020-01-17 | 2023-09-26 | Cannacraft, Inc | Methods for converting CBD to tetrahydrocannabinols |
| CN115551592A (zh) * | 2020-03-17 | 2022-12-30 | 陶里加科学股份有限公司 | 药用大麻素组合物、制造方法和治疗方法 |
| US11786838B2 (en) * | 2020-03-23 | 2023-10-17 | Cannacraft, Inc. | Methods for removing pesticides from Cannabis products |
| EP4188090A4 (en) | 2020-07-28 | 2024-08-14 | Impello Biosciences, Inc. | METHODS AND COMPOSITIONS FOR MODIFYING SECONDARY METABOLITES IN PLANTS |
| CA3203361A1 (en) | 2020-12-31 | 2022-07-07 | Parker BERLING | Compositions comprising cannabis and mushroom extracts, and uses thereof |
| US11345650B1 (en) | 2021-04-08 | 2022-05-31 | MYKU Biosciences LLC | Methods and systems for crystallizing and isolating individual cannabinoids |
| US11465957B1 (en) * | 2021-04-08 | 2022-10-11 | MYKU Biosciences LLC | Methods and systems for crystallizing and isolating individual cannabinoids |
| CN115504862B (zh) * | 2021-06-07 | 2024-07-05 | 南通新世元生物科技有限公司 | 一种大麻萜酚的制备方法 |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
| WO2023250274A1 (en) | 2022-06-22 | 2023-12-28 | Ilera Therapeutics Llc | Enhanced capture and dissolution matrix for cannabinoids and methods of making the same |
| WO2024015780A1 (en) | 2022-07-11 | 2024-01-18 | Ilera Therapeutics Llc | Zlt-007 and methods of treating diabetic neuropathy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002056932A2 (en) * | 2000-10-27 | 2002-07-25 | Emlin Biosciences | Thermal vaporizing device for drug delivery |
| GB2381450B (en) | 2001-10-31 | 2006-05-31 | Gw Pharma Ltd | Compositions for administration of natural or synthetic cannabinoids by vaporisation |
| US20060257463A1 (en) * | 2002-05-31 | 2006-11-16 | University Of Mississippi | Transmucosal delivery of cannabinoids |
| US6946150B2 (en) * | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
| GB0222077D0 (en) | 2002-09-23 | 2002-10-30 | Gw Pharma Ltd | Methods of preparing cannabinoids from plant material |
| EP1644349B1 (en) | 2003-06-24 | 2014-04-09 | GW Pharma Limited | Pharmaceutical compositions comprising cabbinochreme type compounds |
-
2007
- 2007-06-08 US US11/760,364 patent/US8481085B2/en active Active
- 2007-06-14 WO PCT/GB2007/002216 patent/WO2007144628A1/en not_active Ceased
- 2007-06-14 JP JP2009514901A patent/JP5286255B2/ja active Active
- 2007-06-14 CA CA2655094A patent/CA2655094C/en active Active
- 2007-06-14 EP EP07733222.9A patent/EP2037901B1/en active Active
-
2013
- 2013-04-24 US US13/869,247 patent/US20140039043A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009539961A5 (enExample) | ||
| UY26959A1 (es) | Nuevos polvos para inhalación que contienen tiotropio | |
| JP2017533276A5 (enExample) | ||
| EP1937231A1 (en) | Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease | |
| JP2020524151A5 (enExample) | ||
| JP2011500781A5 (enExample) | ||
| ES2929366T3 (es) | Plantas de Cannabis sativa modificadas genéticamente y compuestos cannabinoides modificados para tratamiento de adicción a sustancias y otros trastornos | |
| JP2009537553A5 (enExample) | ||
| WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
| US11504350B2 (en) | Cannabinoid compositions and methods of use thereof | |
| Ahmadi et al. | Scutellaria baicalensis and its constituents baicalin and baicalein as antidotes or protective agents against chemical toxicities: A comprehensive review | |
| DK1715859T3 (da) | Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden | |
| NO20054767L (no) | Sammensetninger omfattende apomorfin for inhalering i lunge | |
| EP4027971A2 (en) | Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids | |
| EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
| CN1294930C (zh) | 一种治疗上呼吸道炎所致咳嗽的药物 | |
| WO2015135372A1 (zh) | 异佛司可林在防治慢性阻塞性肺病中的应用 | |
| UY28096A1 (es) | Nueva formulación pulveurlenta que contiene tiotropio destinada a la inhalación | |
| Yuan et al. | Protective effect of total flavones of rhododendra on ischemic myocardial injury in rabbits | |
| EA201070336A1 (ru) | Ингаляционный азтреонам лизин для лечения нарушений, снижающих качество жизни, обусловленное состоянием здоровья при заболеваниях легких | |
| CN115884770A (zh) | 治疗冠状病毒感染的联用药物及治疗方法 | |
| ATE375146T1 (de) | Schleimdrogenbasierte lutschtablette gegen entzündliche erkrankungen des mund- und rachenraums | |
| EP2570126B1 (en) | Use of melatonin for treating acute alcohol intoxication | |
| NL2022615B1 (en) | Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight | |
| US20210369802A1 (en) | Cannabis plant formulations and methods of delivery |